Virginia Retirement Systems Et Al Ligand Pharmaceuticals Inc Transaction History

Virginia Retirement Systems Et Al

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $617,964 - $874,368	-6,900 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$68.28 - $123.65 $177,528 - $321,490	-2,600 Reduced 27.37%	6,900 $772,000
Q1 2020 May 12, 2020	SELL	$63.37 - $107.88 $202,784 - $345,216	-3,200 Reduced 25.2%	9,500 $691,000
Q4 2019 Jan 27, 2020	BUY	$96.94 - $113.59 $213,268 - $249,898	2,200 Added 20.95%	12,700 $1.32 Million
Q3 2019 Oct 22, 2019	BUY	$86.25 - $120.16 $94,875 - $132,176	1,100 Added 11.7%	10,500 $1.05 Million
Q2 2019 Jul 26, 2019	BUY	$107.38 - $129.34 $32,214 - $38,802	300 Added 3.3%	9,400 $1.07 Million
Q1 2019 Apr 25, 2019	BUY	$105.93 - $142.47 $127,116 - $170,964	1,200 Added 15.19%	9,100 $1.14 Million
Q4 2018 Feb 07, 2019	BUY	$128.36 - $272.13 $38,508 - $81,639	300 Added 3.95%	7,900 $1.07 Million
Q3 2018 Nov 02, 2018	SELL	$211.18 - $274.49 $211,180 - $274,490	-1,000 Reduced 11.63%	7,600 $2.09 Million
Q2 2018 Aug 03, 2018	BUY	$150.77 - $207.98 $1.3 Million - $1.79 Million	8,600 New	8,600 $1.78 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.89B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.